Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Biotechnology Progress
|
March 11, 2024
Simplifying stable CHO cell line generation with high probability of monoclonality by using microfluidic dispensing as an alternative to fluorescence activated cell sorting
Lina Chakrabarti, James Savery, John Patrick Mpindi, et al.
Journal of Cell Science
|
March 6, 2012
A functional genetic screen reveals new regulators of β1-integrin activity
Teijo Pellinen, Juha K Rantala, Antti Arjonen, et al.
Oncotarget
|
January 9, 2013
High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion
Laura Lehtinen, Kirsi Ketola, Rami Mäkelä, et al.
Plos One
|
November 7, 2013
High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells
Vesa Hongisto, Sandra Jernström, Vidal Fey, et al.
Plos One
|
August 14, 2013
ARLTS1 and prostate cancer risk--analysis of expression and regulation
Sanna Siltanen, Daniel Fischer, Tommi Rantapero, et al.
Journal of Cellular and Molecular Medicine
|
January 30, 2018
Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours
Olli-Pekka Pulkka, John-Patrick Mpindi, Olli Tynninen, et al.
Plos One
|
December 11, 2012
Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma
Janne Nordberg, John Patrick Mpindi, Kristiina Iljin, et al.
BMC Genomics
|
March 30, 2011
A cell spot microarray method for production of high density siRNA transfection microarrays
Juha K Rantala, Rami Mäkelä, Anna-Riina Aaltola, et al.
Plos One
|
September 24, 2013
Plasticity of blood- and lymphatic endothelial cells and marker identification
Johannes Keuschnigg, Sirkku Karinen, Kaisa Auvinen, et al.
BMC Cancer
|
July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
Sara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Biotechnology Progress
|
March 11, 2024
Simplifying stable CHO cell line generation with high probability of monoclonality by using microfluidic dispensing as an alternative to fluorescence activated cell sorting
Lina Chakrabarti, James Savery, John Patrick Mpindi, et al.
Journal of Cell Science
|
March 6, 2012
A functional genetic screen reveals new regulators of β1-integrin activity
Teijo Pellinen, Juha K Rantala, Antti Arjonen, et al.
Oncotarget
|
January 9, 2013
High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion
Laura Lehtinen, Kirsi Ketola, Rami Mäkelä, et al.
Plos One
|
November 7, 2013
High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells
Vesa Hongisto, Sandra Jernström, Vidal Fey, et al.
Plos One
|
August 14, 2013
ARLTS1 and prostate cancer risk--analysis of expression and regulation
Sanna Siltanen, Daniel Fischer, Tommi Rantapero, et al.
Journal of Cellular and Molecular Medicine
|
January 30, 2018
Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours
Olli-Pekka Pulkka, John-Patrick Mpindi, Olli Tynninen, et al.
Plos One
|
December 11, 2012
Systemic analysis of gene expression profiles identifies ErbB3 as a potential drug target in pediatric alveolar rhabdomyosarcoma
Janne Nordberg, John Patrick Mpindi, Kristiina Iljin, et al.
BMC Genomics
|
March 30, 2011
A cell spot microarray method for production of high density siRNA transfection microarrays
Juha K Rantala, Rami Mäkelä, Anna-Riina Aaltola, et al.
Plos One
|
September 24, 2013
Plasticity of blood- and lymphatic endothelial cells and marker identification
Johannes Keuschnigg, Sirkku Karinen, Kaisa Auvinen, et al.
BMC Cancer
|
July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
Sara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Page
of 4